The Mold That Saved Millions: Penicillin, 1928–1945
In 1928, a chance mould discovery led Fleming and later Oxford scientists to develop penicillin, the drug that transformed treatment of deadly bacterial infections.
In late summer of 1928, Alexander Fleming returned to his laboratory at St Mary’s Hospital in London and found the sort of bench that would trouble any tidy person: stacks of used culture plates, glassware, and the ordinary mess of a working bacteriologist. Fleming was studying Staphylococcus bacteria, the kind that can cause boils, wound infections, and, in the wrong circumstances, deadly illness.
On one Petri dish, something had gone wrong in an interesting way. A stray mould had contaminated the bacterial culture. Around it was a clear ring, a halo where the bacteria had stopped growing or had been killed. The plate looked like a cloudy pond with a clean circle cut through it.
This is the famous “dirty dish after a holiday” story, and it is broadly true. Fleming did notice an unusually contaminated plate after time away. But the neat version has been polished by retelling. The exact timing, and precisely how the mould drifted in, are less certain. Science often begins not with a lightning bolt, but with someone refusing to throw away an odd result.
Fleming identified the mould as a member of the Penicillium group and named the bacteria-killing substance it released “penicillin.” He was not the first person to suspect that moulds could suppress microbes; others had seen related effects before. His achievement was to recognize this particular effect, test it, and publish it.
But penicillin did not become a medicine in 1928. For nearly a decade it was more like a beautiful key that opened no usable door. The substance was unstable, hard to purify, and difficult to make in quantity. Fleming was a gifted bacteriologist, but his laboratory was not equipped to turn a fragile mould product into a dependable drug.
So penicillin slipped into the background of the scientific literature. Meanwhile, doctors still fought infections with surgery, drainage, antiseptics, and luck. Before antibiotics, a shaving cut, a childbirth infection, or a blister rubbed raw on a long walk could become a life-threatening crisis.
The story came back to life at Oxford in the late 1930s. Howard Florey, an Australian pathologist, and Ernst Chain, a German-born biochemist who had fled Nazi Germany, led a team that revisited Fleming’s neglected finding. Norman Heatley, a brilliant and practical scientist, became essential to the effort. Their task was not glamorous: grow the mould, extract the active substance, purify it, measure it, and somehow make enough to test.
The early production methods looked almost improvised. The Oxford team grew mould in bedpans, tins, and shallow ceramic vessels. Every drop mattered. Heatley developed ways to recover penicillin from the mould broth, and even from patients’ urine, because the body excreted much of the precious drug unchanged. In those days, wasting penicillin was unthinkable.
In 1940, the team tested it in mice infected with lethal bacteria. The untreated mice died. The mice given penicillin survived. It was the kind of result that makes a laboratory fall quiet, because everyone understands the scale of what may be happening.
Then came the first major human test. In early 1941, Albert Alexander, a police officer, was treated at the Radcliffe Infirmary in Oxford. He had a severe infection that was spreading through his body. The often repeated story says it began with a rose-thorn scratch, but that detail is uncertain.
What is certain is that penicillin helped him at first. His fever dropped. His condition improved. For a few days, the impossible seemed possible. Then the supply ran out, even after the team recycled what they could from his urine. The infection returned, and Alexander died.
It was a heartbreaking proof of concept. Penicillin could save people, but only if enough could be made. The Second World War made that need urgent. Wounds, burns, and surgery were killing soldiers not only through injury, but through infection.
Britain had limited industrial capacity under wartime pressure, so Florey and Heatley travelled to the United States in 1941. American government laboratories, universities, and pharmaceutical companies joined the scale-up effort. The problem became biology, chemistry, engineering, and logistics all at once.
One famous breakthrough came from a mouldy cantaloupe bought at a market in Peoria, Illinois. Researchers at a U.S. Department of Agriculture laboratory were hunting for better strains. A laboratory worker often identified as Mary Hunt, nicknamed “Mouldy Mary,” brought in the fruit. Its mould, Penicillium chrysogenum, produced much more penicillin than Fleming’s original strain.
Scientists improved production further through strain selection and mutation, using X-rays and ultraviolet light. Industry moved from shallow trays to deep fermentation tanks, closer to brewing beer on a vast scale. By D-Day in June 1944, penicillin was available in amounts that would have seemed impossible a few years earlier.
Its impact was enormous. Penicillin transformed treatment for wound infections, pneumonia, sepsis, syphilis, and other bacterial diseases. It did not work against viruses like influenza or the common cold. But for many bacterial infections that had once terrified families and doctors, it changed the odds.
In 1945, the Nobel Prize in Physiology or Medicine went to Fleming, Florey, and Chain. The prize honored not just a lucky observation, but the long chain of work that made it useful.
That same year, Fleming warned that careless use could teach bacteria to resist penicillin. He was right. Bacteria evolve quickly, and antibiotics used unnecessarily, underdosed, or stopped too soon can give resistant strains an advantage.
So the story of penicillin is not only a story about a miracle mould. It is about attention, persistence, teamwork, and caution. A contaminated dish opened the door, but years of disciplined science walked through it. On the plate, the clear ring around the mould remained: a small warning as well as a promise.